The Endocrine Society has released new guidelines on vitamin D supplementation, recommending against routine screening for deficiency in most people and suggesting specific intake levels for different age groups and conditions. Children, teens, adults over 70, pregnant women, and those with pre-diabetes may benefit from higher vitamin D intake. The guidelines emphasize the importance of consulting healthcare providers to ensure appropriate vitamin D levels, as excessive intake can be harmful.
The Endocrine Society's new guidelines advise against routine vitamin D testing in healthy individuals and recommend limiting supplementation to specific risk groups, such as children, pregnant people, adults over 75, and those with prediabetes. The guidelines emphasize adhering to the National Academy of Medicine's recommended daily intakes and highlight the need for more large-scale clinical trials to determine optimal vitamin D levels and intake.
The Endocrine Society's new Clinical Practice Guideline advises against excessive vitamin D supplementation and unnecessary testing in healthy adults under 75. It recommends higher vitamin D intake for children, the elderly over 75, pregnant individuals, and adults with prediabetes. The guideline, based on clinical trials, aims to address vitamin D requirements for disease prevention in generally healthy populations.
Continuous glucose monitors (CGMs) with alarm settings that generate too many alerts may lead to alarm fatigue in teenagers with diabetes, causing them to ignore the devices, according to a study presented at the 2023 annual meeting of the Endocrine Society. The study analyzed two weeks of real-time CGM alarm settings from 150 children with diabetes treated at Indiana, and found that alarm settings often varied widely from thresholds recommended by the University of Colorado’s Barbara Davis Center for Diabetes. Experts advise parents and children to be thoughtful about setting their CGM alarm thresholds to be most useful to them.
The Endocrine Society has released a statement on hormones and aging, covering nine parts or axes, including growth hormone, adrenal, ovarian, testicular, thyroid, osteoporosis, vitamin D deficiency, type 2 diabetes, and water metabolism. The statement aims to clarify misunderstandings and provide a concise summary of available therapies, clinical trial data, key points, and research gaps. It tackles controversial areas such as hormone replacement therapy, diabetes treatment goals, and vitamin D supplementation in older adults. The document is a one-stop-shop for clinicians to learn about hormonal changes in aging and when treatment is and isn't appropriate.
The American Medical Association (AMA) has passed a resolution at its annual meeting to protect gender-affirming care, opposing legal penalties for patients and their families accessing such care, protecting doctors from legal and physical threats, and advocating against legislation that limits gender-affirming care. The AMA has publicly supported gender-affirming medicine for years and has also shown support for intersex people. The resolution was introduced by the Endocrine Society and passed with limited opposition. The AMA also passed resolutions opposing mandated reporting of LGBTQ+ identities and de-emphasizing the use of BMI in assessing patient health.
